课题基金 / 基金详情

TRAINING PROGRAM IN ACADEMIC MEDICAL ONCOLOGY/HEMATOLOGY

TRAINING PROGRAM IN ACADEMIC MEDICAL ONCOLOGY/HEMATOLOGY
学术医学肿瘤学/血液学培训计划
批准号:
6744395
负责人:
DAVID H BOLDT
金额:
$3.57万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-07-01 至 2005-04-30

项目摘要

项目成果

DAVID H BOLDT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this competing continuation Train Program Application is to extend the opportunity that exists at the University of Texas Health Science Center at San Antonio for the development and training of new physician/scientists in academic Medical Oncology and Hematology. This integrated 3 to 4-year program primarily for postdoctoral M.D. candidates (postdoc Ph.D. or Pharm.D.) candidates occasionally selected) begins with an intensive clinical year to obtain the experience necessary for board eligibility and/or translational research under the preceptorship of one of 17 outstanding and experienced faculty investigators. Research training is structured around 5 of the research programs sponsored by our NIH-designated Comprehensive Cancer Center (San Antonio Cancer Institute of SACI) including: Breast Cancer, Growth Factors, Drug Development, Molecular Genetics, and Cancer Prevention and Health Promotion. The faculty preceptors, representing 7 different departments, belong to one or more of these multi-departmental research programs. Research training is supplemented by unique formal coursework in medical writing and grant preparation, biostatistics methodology, clinical oncology, biology, molecular biology and ethics, and by a series of conferences, research seminars, data review sessions and research programs meetings. Medical Oncology trainees are selected from applicants who have completed a 3-year medical residency program. Trainees (2 Year 4 and 2 Year 5) selected for this Research Training Program must have a commitment to a career as a physician/scientist in academic medicine and must have a record of achievement indication promise as an academic investigator. Candidates with M.D. and Ph.D. degrees or those with prior laboratory research experience are given preference. Recruitment of minority trainees is also a goal to be accomplished through our Minority Recruitment Program that has been successful in the past. Trainees will engage in in depth training in one of several areas including and cellular biology of breast cancer, oncogenes and suppressor genes, regulation of gene expression, drug resistance, growth factors and signal transduction pathways, bone cell metabolism in malignancy, molecular genetics and hematopoietic stem cell differentiation. Research training is for a minimum of 2 years. These projects involve collaborations with faculty from other Cancer Center Research Programs and other UTHSCSA Departments, both clinical and basic science, to ensure an optimal training experience. Trainees completing this program will have acquired the clinical, research, teaching, and administrative skills that will provide them with a strong foundation for competitive research careers as physician/scientists.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
A comparison of frozen and fresh platelet concentrates in the support of thrombocytopenic patients.
冷冻和新鲜血小板浓缩物对血小板减少症患者支持的比较。
DOI: 10.1046/j.1537-2995.1986.26687043618.x
发表时间: 1986
期刊: Transfusion
影响因子: 2.9
作者: [Towell,BL, Levine,SP, Knight3rd,WA, Anderson,JL]
通讯作者: Anderson,JL
Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
癌症患者积液中的免疫反应性α转化生长因子活性作为肿瘤负荷和患者预后的标志。
DOI: --
发表时间: 1988
期刊: Cancer research
影响因子: 11.2
作者: [Arteaga,CL, Hanauske,AR, Clark,GM, Osborne,CK, Hazarika,P, Pardue,RL, Tio,F, VonHoff,DD]
通讯作者: VonHoff,DD
Transcriptional regulation of transferrin receptor expression by cultured lymphoblastoid T cells treated with phorbol diesters.
用佛波二酯处理的培养的类淋巴母细胞 T 细胞对转铁蛋白受体表达的转录调节。
DOI: --
发表时间: 1989
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Alcantara,O, Denham,CA, Phillips,JL, Boldt,DH]
通讯作者: Boldt,DH
Rationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin.
干扰素 alfa-2b 加阿霉素 I 期临床试验的基本原理和实施。
DOI: --
发表时间: 1986
期刊: Seminars in oncology
影响因子: 4
作者: [VonHoff,DD, Sarosy,G, Brown,TD, Kuhn,JG, Kisner,DL]
通讯作者: Kisner,DL
8
    FACSTAR PLUS UPGRADE--TURBOSORTING UV LASER WORKSTATION
    NOVEL IRON/HEMIN RESPONSIVE GENES IN HEMATOPOIESIS
    NOVEL IRON/HEMIN RESPONSIVE GENES IN HEMATOPOIESIS
    NOVEL IRON/HEMIN RESPONSIVE GENES IN HEMATOPOIESIS
    海外基金